These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35392611)

  • 21. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of various uropathogens on crystallization of urine mineral components caused by Proteus mirabilis.
    Torzewska A; Bednarska K; Różalski A
    Res Microbiol; 2019 Mar; 170(2):80-85. PubMed ID: 30521846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of green fluorescent protein to assess urease gene expression by uropathogenic Proteus mirabilis during experimental ascending urinary tract infection.
    Zhao H; Thompson RB; Lockatell V; Johnson DE; Mobley HL
    Infect Immun; 1998 Jan; 66(1):330-5. PubMed ID: 9423875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Characterization of
    Kyser AJ; Mahmoud MY; Johnson NT; Fotouh B; Steinbach-Rankins JM; Gilbert NM; Frieboes HB
    ACS Biomater Sci Eng; 2023 Jul; 9(7):4277-4287. PubMed ID: 37367532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urease-positive bacteriuria and obstruction of long-term urinary catheters.
    Mobley HL; Warren JW
    J Clin Microbiol; 1987 Nov; 25(11):2216-7. PubMed ID: 3320089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro.
    Imani Rad H; Peeri H; Amani M; Mohammadnia A; Ogunniyi AD; Khazandi M; Venter H; Arzanlou M
    Microb Pathog; 2019 Jul; 132():293-301. PubMed ID: 31082531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Urinary calculi and infection].
    Trinchieri A
    Urologia; 2014; 81(2):93-8. PubMed ID: 24874306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections.
    Thänert R; Reske KA; Hink T; Wallace MA; Wang B; Schwartz DJ; Seiler S; Cass C; Burnham CA; Dubberke ER; Kwon JH; Dantas G
    mBio; 2019 Aug; 10(4):. PubMed ID: 31455657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proteomics analysis of urine and catheter-associated biofilms in spinal cord injury patients.
    Garcia-Marques FJ; Zakrasek E; Bermudez A; Polasko AL; Liu S; Stoyanova T; Brooks JD; Lavelle J; Pitteri SJ
    Am J Clin Exp Urol; 2023; 11(3):206-219. PubMed ID: 37441441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small-molecular inhibitor against Proteus mirabilis urease to treat catheter-associated urinary tract infections.
    Milo S; Heylen RA; Glancy J; Williams GT; Patenall BL; Hathaway HJ; Thet NT; Allinson SL; Laabei M; Jenkins ATA
    Sci Rep; 2021 Feb; 11(1):3726. PubMed ID: 33580163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Antimicrobial Susceptibility of Bacterial Uropathogens Isolated from Pediatric Patients at Yekatit 12 Hospital Medical College, Addis Ababa, Ethiopia.
    Merga Duffa Y; Terfa Kitila K; Mamuye Gebretsadik D; Bitew A
    Int J Microbiol; 2018; 2018():8492309. PubMed ID: 30386381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morganella morganii urease: purification, characterization, and isolation of gene sequences.
    Hu LT; Nicholson EB; Jones BD; Lynch MJ; Mobley HL
    J Bacteriol; 1990 Jun; 172(6):3073-80. PubMed ID: 2345135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.
    Guiton PS; Cusumano CK; Kline KA; Dodson KW; Han Z; Janetka JW; Henderson JP; Caparon MG; Hultgren SJ
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4738-45. PubMed ID: 22733070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: results based on a retrospective study from a tertiary hospital.
    Ma KL; Wang CX
    Am J Infect Control; 2013 Jul; 41(7):601-6. PubMed ID: 23352074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uropathogens and urinary tract concretion formation and catheter encrustations.
    Hedelin H
    Int J Antimicrob Agents; 2002 Jun; 19(6):484-7. PubMed ID: 12135838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cranberry derivatives enhance biofilm formation and transiently impair swarming motility of the uropathogen Proteus mirabilis HI4320.
    O'May C; Amzallag O; Bechir K; Tufenkji N
    Can J Microbiol; 2016 Jun; 62(6):464-74. PubMed ID: 27090825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Virulence factors in Proteus spp. bacteria isolated from urinary tract infections: their detection and importance].
    Klin Mikrobiol Infekc Lek; 2011 Aug; 17(4):129-34. PubMed ID: 22052099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High burden of ESBL- producing Klebsiella spp., Proteus mirabilis, Enterobacter cloacae and Pseudomonas aeruginosa in diagnosed cases of urinary tract infection in a Nigerian Teaching Hospital.
    Adekanmbi AO; Akinlabi OC; Usidamen S; Olaposi AV; Olaniyan AB
    Acta Microbiol Immunol Hung; 2022 Jun; 69(2):127-134. PubMed ID: 35895567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A metaproteomics approach to elucidate host and pathogen protein expression during catheter-associated urinary tract infections (CAUTIs).
    Lassek C; Burghartz M; Chaves-Moreno D; Otto A; Hentschker C; Fuchs S; Bernhardt J; Jauregui R; Neubauer R; Becher D; Pieper DH; Jahn M; Jahn D; Riedel K
    Mol Cell Proteomics; 2015 Apr; 14(4):989-1008. PubMed ID: 25673765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of catheter-associated urinary tract infections by Gram-negative bacilli and their ESBL and carbapenemase production in specialized hospitals of Bahir Dar, northwest Ethiopia.
    Asmare Z; Awoke T; Genet C; Admas A; Melese A; Mulu W
    Antimicrob Resist Infect Control; 2024 Jan; 13(1):10. PubMed ID: 38273339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.